Digital CBT May Help Cut Risk for Depression, Anxiety, EDs
Digital cognitive-behavioral therapy-guided self-help is linked to reduced risk for mental disorders such as depression and anxiety in college students, ...
A cosmic case of mistaken identity that can only be solved right now
The galaxy MoM-z14 was called a “cosmic miracle” by its discoverersJ. DePasquale (STScI) I’m certain scientists before me have thought ...
AstraZeneca’s New Oral GLP-1 Led to 10.5% Weight Loss
Share on PinterestAstraZeneca’s new oral GLP-1 pill showed promising results for weight loss and blood sugar in a phase 2 ...
Why we should all take quantum physics extremely personally
Embracing quantum physics could make you see the world differentlyKamilSD / Alamy In December 2019, a bad tooth almost killed ...
Urinary Symptoms in Men: Do Herbs Like Saw Palmetto Help?
Herbal treatments for benign prostatic hyperplasia may improve urinary symptoms in some men, although evidence remains limited and results vary ...
Anti-CGRPs in Early Pregnancy Linked to Miscarriage Risk
Use of anti-CGRP monoclonal antibodies during early pregnancy was associated with an increased risk for spontaneous abortion results of a ...
Europe’s Medical Loophole for Banned Doctors
A doctor struck off in France kept practicing in Belgium, exposing how gaps in EU medical oversight can let sanctioned ...
APA Poll: US Anxiety Levels Continue to Climb in 2026
Anxiety levels are rising in the US over last year, driven mostly by current global events and expenses, along with ...
‘Lives still at risk’ from unregulated baby sleep industry after BBC investigation
She outlined existing provision for new parents, including the Healthy Babies programme which "supports new parents and families by offering ...
Tolerability Concerns for GLP-1/Glucagon Agonist in Obesity, MASLD
NEW ORLEANS -- Treatment with survodutide led to significant weight loss and reductions in liver fat in phase III trials ...
Dual Incretin Agonist Survodutide Benefits Liver in Phase 3
The glucagon receptor/GLP-1 receptor dual agonist reduces weight, visceral fat, and liver fat. Medscape Medical News Source link : https://www.medscape.com/viewarticle/dual-incretin-agonist-survodutide-benefits-liver-phase-3-2026a1000j5d?src=rss ...
Flesh-Eating Cattle Parasite Spreads Beyond Texas as New Screwworm Cases Are Found
Two more cases of the New World screwworm have been confirmed, including one outside the main cluster in Texas, demonstrating ...
NICU Babies More Likely to Miss Rotavirus Vax
Among U.S. children born after the introduction of rotavirus vaccines, extremely preterm birth predicted 14.6-fold higher odds of not getting ...
Primitive Reflexes May Predict Dementia
Frontal release signs predicted higher 7-year dementia risk in cognitively normal adults.These signs are simple neurologic exam findings associated with ...
Large Study Links GLP-1s to Lower Risk of Multiple Cancers
Patients taking GLP-1 receptor agonists for weight loss had a 41% lower risk of obesity-associated cancers compared with patients prescribed ...
Liver-Directed Insulin: A New Way to Reduce Hypoglycemia?
Study findings suggest that a liver-targeted formulation of fast-acting insulin may reduce the risk for hypoglycemia in patients with type ...
GLP-1, Amylin Analog Combo Cuts Blood Sugar, Weight in Diabetes Trials
NEW ORLEANS -- A fixed-dose combination of novel amylin analog cagrilintide and semaglutide, given once weekly, lowered blood glucose and ...
Leaders Resign From ADA After Experts Booted From Meeting
NEW ORLEANS -- In the wake of clinicians and researchers being kicked out of the American Diabetes Association (ADA) meeting ...
Maternal RSV Vaccine Linked to Lower Risk of Infant Hospitalization
Data from the previous MATISSE trial showed that the maternal RSV vaccine was efficacious against RSV-associated hospitalization in infants, but ...
Moving Beyond GLP-1s: Preclinical Acceleration, Innovation
Next-generation obesity therapeutics aim to counter weight rebound, decrease side effects, and support weight maintenance. Medscape Medical News Source link ...
